Here at Throne Biotechnologies, we are pleased to announce Dr. Theodore Mazzone, M.D., as our new chief medical officer.
Dr. Mazzone has been a clinical physician, scientist, and professor for nearly forty years. He is an internationally-acclaimed endocrinologist having contributed significantly to the diabetes field in both patient facing practice and scientific research.
He graduated from Northwestern University Feinberg School of Medicine with his doctor of medicine degree with distinction in 1977, before then completing his residency in Internal Medicine at the University of California Los Angeles in 1980, and his research and senior fellowship in Endocrinology, Metabolism, & Nutrition at the University of Washington Seattle in 1983. Since then, Dr. Mazzone has gone on to publish over 135 scientific articles, and has been named every year as one of “America’s Top Doctors,” “Castle Connolly’s America's Top Doctors,” and “Chicago’s Top Doctors,” since 2001.
Dr. Mazzone was the Chairman of the Department of Medicine at NorthShore University’s Health System, a six-hospital integrated healthcare system that is nationally ranked and is a major affiliate of the University of Chicago Pritzker School of Medicine He has also served in other leadership positions, within organizations such as the American Heart Association, the American Diabetes Association, and the American Board of Internal Medicine for Endocrinology and Metabolism.
He was also a tenured Professor of Medicine at Rush University Medical Center, as well as the University of Illinois, where he was the founder and Director of the University of Illinois at Chicago’s Center for Clinical and Translational Science (2003) and continued as the center’s director for the following eight years.
At the University of Illinois, Dr. Mazzone worked closely with Throne’s founding scientist, Dr. Yong Zhao, on the foundational research that eventually led to the Stem Cell Educator Therapy, Throne’s flagship technology for the cure of type 1 diabetes and other autoimmune diseases.
“Over the last 10 years, the Stem Cell Educator Therapy has seen some fantastic and inspiring clinical results,” said Dr. Mazzone. “I am now happy to rejoin the effort to bring this technology to patients who have diseases which are devastating in terms of their impact on the quality of life and duration of life and for which there is no cure.”
Welcome Dr. Mazzone, we are excited and thrilled to have you on our team!